1 Jan 2025Open access
Image guided minimally invasive surgical approaches to tumors around sellaPublisher siteInternational Journal of Neurology Sciences, Soft tissue tumor case studies
UniversitiesEjaz Ahmed
Active, last published 2026
In renal transplantation outcomes and treatments
Ejaz
Ahmed
Scholar“Research focused on Renal Transplantation Outcomes and Treatments and adjacent fields.”
Claim Your Profile24
H-index
1.8k
Citations
Ejaz has not officially claimed their profile. If you are Ejaz, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
jaz Ahmed is a researcher working on Renal Transplantation Outcomes and Treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ejaz's work has been cited 1,815 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Renal Transplantation Outcomes and Treatments×33Organ Donation and Transplantation×18Organ Transplantation Techniques and Outcomes×16Renal Diseases and Glomerulopathies×14Systemic Lupus Erythematosus Research×12
04 · Where I am
Affiliations
Affiliation details will appear once this profile is updated.
05 · Selected work
Recent publications
2 works17 Nov 2024Open access
Descriptive study for recurrent idiopathic acute pancreatitis cases admitted in Kasr El-Ainy endoscopy unitPublisher siteMinia Journal of Medical Research, Pancreatitis Pathology and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ejaz?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you